65,437 trials
Non-small Cell Lung Cancer
Primary: Number of Participants Who Experienced Serious Adverse Events (SAE), Adverse Events (AE) Leading to Discontinuation, or Death — 4; 10; 8; 3 Participants
Anxiety
Primary: Mean Change From Baseline in Pediatric Anxiety Rating Scale (PARS) at Treatment Completion — 11; -1 score on a scale
Postoperative Pain · Postoperative Complications · Gingival Recession
Primary: Post-operative Pain: VAS — 20.00; 62 score on a scale
Menopause · Hypertension
Primary: Blood Epinephrine Levels — 39.3; 46.2 pg/mL
Signs and Symptoms
Primary: Sensitivity and Specificity (Percentage)
Leiomyoma
Primary: mg Equivalent Morphine Used Until Discharge From Recovery Room to Control Pain Level Below 4/10 (VAS) — 11; 5.1 mg
Hypertension · Insomnia
Primary: Change in Sleep Systolic Blood Pressure — -1.8; -4.4 mmHg
Prescription Drug Abuse (Not Dependent)
Primary: Current Opioid Misuse Measure (COMM) — .72; .71; .62; .63 score on a scale — p=.72
Premature Birth of Newborn · Family · Immature Newborn
Primary: Parental Self-Efficacy — 74.94; 74.75; 72.7; 72.6 score on a scale — p=0.73
Dizziness · Brain Injury
Primary: Peripheral Vestibular Function (Vestibulo-ocular Reflex/Semicircular Canal): Caloric Weakness — 8.8; 14.7; 12.3; 7.1 percentage of caloric weakness
Vaginal Atrophy
Primary: Variation in Serum Levels of Follicle Stimulating Hormone (FSH) — -2.8; 1.4 mIU/ml — p=0.10
Hiatal Hernia With Gastroesophageal Reflux Disease · Gastroesophageal Reflux · GERD
Primary: Number of Subjects Who Required a Revision of the Index Surgery. — 0 Participants
Lymphoma · Hodgkin Disease · Lymphoma, Non-Hodgkin
Primary: 68Ga-DOTANOC Uptake in Lymphomas With PET/CT — 3.1 Standardized Uptake Value
Gastroesophageal Reflux Disease
Primary: Pharmacokinetic Analysis in Obese Children After One Single Oral Dose of Pantoprazole (Cmax). — 4.27; 4.1 mcg/ml
AIDS/HIV
Primary: Number of Participants With Abstinence — 8; 1 Participants — p=< 0.05